Aggressive stimulus measures for pharmaceutical industry needed

Published: 2003-03-11 06:59:00

Updated: 2003-03-11 06:59:00

Rhee Jang-han, new chief-director of the Korea Pharmaceutical Manufacturers Association, said that the KPMA will concentrate its efforts to revamp the current reimbursement price system to a level that is sufficient to fund the heavy R&D investments necessary to develop new products, adding that ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK